Effect of bromocriptine on dystonic-athetoid dyskinesias in mentally retarded patients.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001264:Athetosis / Q000188:drug therapy*; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004421:Dystonia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000097:blood / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000150:complications / Q000188:drug therapy*; D011388:Prolactin / Q000097:blood
D001971:Bromocriptine; D011388:Prolactin